K-numberK252862
Device nameElectric Wheelchair (DH01126)
ApplicantFoshan Dahao Medical Technology Co., Ltd.
Product codeITI
Device classClass II
Decision dateDec 8, 2025
DecisionSubstantially Equivalent
Regulation890.3860
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The DH01126 Electric Wheelchair is a motor-driven, foldable personal mobility device powered by a lithium-ion battery and controlled via a joystick. It is intended for disabled or elderly individuals with limited mobility, suitable for indoor and outdoor use on flat surfaces near buildings.

Technological characteristics

The device features two 24V/150W brushless DC motors, a 24V10Ah lithium-ion battery, a carbon-fiber foldable frame, joystick speed control, and hub motor/electromagnetic brake assemblies on rear wheels. Minor differences from the predicate include lower motor power (150W vs 200W), smaller battery capacity (10Ah vs 12Ah), slightly reduced cruising range (12.4 km vs 16.5 km), and lower maximum speed (1.3 m/s vs 1.66 m/s).

Test standards cited

ISO 7176 series (parts 1–25) covering stability, braking, energy consumption, dimensions, speed, obstacle climbing, seating, structural strength, control systems, electromagnetic compatibility, and batteries; ISO 10993 series (parts 1, 5, 10, 23) for biocompatibility; IEC 60601-1-2:2020 and IEC 60601-4-2 for electromagnetic safety; and ISO 16840-10:2021/AMD-1 2024 for flame resistance.

Substantial equivalence argument

The proposed device is substantially equivalent because it shares the same product code (ITI), regulatory classification (Class II), intended use, patient population, and general structure as the predicate Powered Wheelchair (NXN20-209). Although minor differences exist in motor power, battery capacity, and performance metrics, these do not raise new safety or effectiveness concerns because both devices comply with identical ISO 7176 and biocompatibility standards, and nonclinical testing confirmed the subject device performs as intended without adverse effects.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →